Taisho Pharmaceutical
Taisho Pharmaceutical head office building | |
Native name | 大正製薬ホールディングス株式会社 |
|---|---|
Romanized name | Taishō Seiyaku Hōrudingusu kabushiki gaisha |
| Company type | Private (Kabushiki gaisha) |
| TYO: 4581 | |
| ISIN | JP3442850008 |
| Industry | Pharmaceutical |
| Founded | October 12, 1912 |
| Headquarters | Toshima-ku, Tokyo 170-8655 , Japan |
Area served | Worldwide |
Key people | Akira Uehara (President and CEO) |
| Products | |
| Revenue | JPY 280 billion (FY 2017) (US$ 2.6 billion) (FY 20177) |
| JPY 31.6 billion (FY 2017) (US$ 298 million) (FY 2017) | |
| Owner | Shigeru Uehara (100%) |
Number of employees | 6,340 (consolidated, as of March 31, 2018) |
| Website | www.taisho.co.jp |
| Footnotes / references | |
Taisho Pharmaceutical Co., Ltd. (大正製薬株式会社, Taishō Seiyaku Kabushiki-gaisha), commonly known as Taisho, is a Japanese multinational pharmaceutical company based in Tokyo.